[Effect of the VOLANTIN resilience promotion program on children with an alternative residential system]. / Efectos de la implementación del programa de promoción de la resiliencia "VOLANTÍN" en niños(as) con sistema de cuidados alternativo residencial.

INTRODUCTION: Internationally, there are resilience promotion programs applied to children in residential alterna tive care with favorable results. The application of the resilience promotion program "VOLANTÍN" has shown to be effective in different groups of school-age children, favoring the development of resilience. OBJECTIVE: To describe the results of the implementation of the "VOLANTÍN' program on the level of resilience, self-concept, and emotional symptoms in children aged 7-12 years in resi dential alternative care (foster care). SUBJECTS AND METHOD: descriptive, longitudinal study. The "VO LANTÍN" program was implemented in a sample of 15 foster children between 7-12 years old. The variables measured were the "Escala de Resiliencia Escolar" (ERE), the Piers-Harris Children's Self Concept Scale, the Anxiety Self-report for Children and Adolescents (AANA), and the Children's Depression Inventory (CDI) at the beginning, at the end, and 3 months after the end of the program, and then were analyzed statistically by nonparametric test. RESULTS: At the beginning, the end, and three months after the program implementation, there was a significant increase in the total sco res of ERE (p0.045), subscales "networks-models" (p0.002) and "external resources" (p0.018); and Self-concept (p0.005), subscales "behavior" (p0.045) and "popularity" (p0.03). AANA total scores decreased significantly (p0.004) as well as the subscales "panic/somatic" (p0.025) and "generalized anxiety" (p0.009). CDI scores decreased, but not significantly. CONCLUSION: The application of the resilience promotion program "VOLANTÍN' increased resilience and self-concept scores and decrea sed anxious symptoms in children aged 7-12 years.

Measurement of the absolute gamma-ray emission intensities from the decay of 147Nd.

The 2011 Decay Data Evaluation Project (DDEP) evaluation for 147Nd includes recommended absolute emission intensities for the two main gamma-rays at 91.105 (2) keV and 531.016 (22) keV of 0.284 (18) and 0.127 (9) respectively, i.e. with uncertainties of 6.3% and 7.1%. These large uncertainties stem from inconsistencies in the published data and are unfit for modern purposes, since the production of 147Nd is used as an important neutron flux dosimeter. The LNE-LNHB has undertaken new absolute gamma-ray emission intensity measurements. The results of these measurements will be presented, along with a full uncertainty budget, and their effect on the recommended data uncertainties will be discussed.

Multi-elemental Nd, Sm, Eu, Gd isotope ratio measurements by stop-flow isotachophoresis coupled to MC-ICPMS.

In this study, a new analytical procedure based on isotachophoresis (ITP) coupled to a multi collector inductively coupled plasma mass spectrometer named Stop-Flow-ITP-MC-ICPMS is developed for exhaustive and high-precision multi-elemental isotopic characterization. We demonstrate that Stop-Flow-ITP makes it possible to stop the analytes migration several times for a duration compatible with the detector configuration changes without losing the separation performance. With this procedure, isotope ratio measurements of four lanthanides of interest for nuclear applications (Nd, Sm, Eu and Gd) were obtained with a reproducibility better than 0.4% in a single analysis with only 20ng of each element. A nebulization interface between ITP and MC-ICPMS composed of a dual inlet spray chamber and a multiple flow stream valve made it possible to perform isotopic reference standard injections for on-line mass bias correction by the sample standard bracketing approach. The flexibility of the Stop-Flow-ITP-MC-ICPMS procedure opens the way to online determination of isotope ratio measurements of multiple analytes present in a sample in a single analysis.

Expresión de óxido nítrico sintetasa en mucosa sinusal de pacientes portadores de sinusitis crónica versus controles / Expression of nitric oxide synthase in sinus mucosa of chronic sinusitis patients vs controls

Introducción: El óxido nítrico producido en las cavidades paranasales juega un importante rol en la fisiología nasal ya que aumenta la frecuencia del batido ciliar, optimiza el barrido mucociliary tiene un efecto bacteriostático y virustático. Diversos estudios muestran que el óxido nítrico nasal exhalado en pacientes con rinosinusitis crónica es significativamente más bajo que en sujetos sanos. Esto podría estar determinado por una alteración en la difusión del óxido nítrico a través de los ostia de drenaje obstruidos o por una menor producción de óxido nítrico por parte de los portadores de rinosinusitis crónica. En este último caso, esto podría corresponder al evento primario en la etiopatogenia de la rinosinusitis crónica. Objetivos: Estudiar y comparar cualitativamente con técnica de inmunohisto-química la expresión de las isoformas e-NOS e I-NOS de la óxido nítrico sintetasa en mucosa sinusal de pacientes con rinosinusitis crónica y pacientes controles, sin patología rinosinusal infecciosa o alérgica. Material y método: Para responder a esta interrogante se realizó un estudio comparativo de casos y controles, con el objetivo de cuantificar con técnica de inmunohistoquímica la expresión de las isoformas endotelial e inducible de la óxido nítrico sintetasa en mucosa sinusal de pacientes con rinosinusitis crónica y pacientes controles sin patología rinosinusal infecciosa o alérgica. Resultados: Ingresan al estudio un total de 11 pacientes. Seis de ellos son el grupo control y 5 con sinusitis crónica. Ambos grupos presentan resultados similares. Conclusión: Los resultados no muestran ninguna diferencia en la expresión de óxido nítrico sintetasa, tanto en su isoforma endotelial como inducible, en la mucosa sinusal de pacientes portadores de rinosinusitis crónica comparado con sujetos sanos.

Introduction. Nitric oxide produced in the paranasal sinuses plays an important role in nasal physiology because it increases ciliary beat frequency, improves mucociliary clearance and has a bacteriostatic and virustatic effect. Several studies have shown that exhaled nasal nitric oxide was substantially lower in chronic sinusitis patients, compared to healthy subjects. This could be determined by altered nitric oxide diffusion through obstructed drainage ostia, or by chronic sinusitis patients having lower nitric oxide production. Aims. To qualitatively compare by immunocytochemistry the expression of the iNOS and eNOS isoforms of nitric oxide synthase in the sinus mucosa of chronic sinusitis patients and control subjects. Materials and methods. A case-control comparative study was carried out in order to compare by immunocytochemistry the expression of inducible and epithelial isoforms of nitric oxide synthase in nasal mucosa of chronic sinusitis patients and control subjects, with no infectious or allergic rhinosinusal pathology. Results. The results show no difference in the expression of the inducible or epithelial isoform of nitric oxide synthase in the nasal mucosa of chronic sinusitis patients as compared to healthy subjects.

Antimycobacterial activity of N1-[1-[3-aryl-1-(pyridin-2-, 3- or 4-yl)-3-oxo] propyl]-2-pyridinecarboxamidrazones.

Infections caused by non-tuberculous mycobacteria and multidrug-resistant Mycobacterium tuberculosis are difficult to treat, and so new compounds potentially active against these bacteria are being sought. A series of 2-pyridinecarboxamidrazone derivatives, recently synthesized, have been evaluated for their inhibitory activity against 17 Mycobacterium avium isolates; the agar dilution method showed different degrees of susceptibility to the new molecules. Four molecules, three of which are chlorine derivatives, inhibited 94% of the strains tested with an MIC of 32 mg/L. These data indicate that these new pyridine-2-carboxamidrazones merit further study as antimycobacterial agents.

Synthesis and antimycobacterial activity of [5-(pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid arylidene-hydrazide derivatives.

[5-(Pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid arylidene-hydrazide derivatives were synthesized and tested for their in vitro antimycobacterial activity. Some compounds showed a feable activity against a strain of Mycobacterium tuberculosis and a strain of Mycobacterium avium.

Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives.

5-Aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazole derivatives were synthesized and tested for their in vitro antimycobacterial activity. The compounds showed an interesting activity against a strain of Mycobacterium tuberculosis and a human strain of M. tuberculosis H4.

Synthesis and antimycobacterial activity of some 4H-1,2,4-triazin-5-one derivatives.

6-[(Arylmethylenamino)carbonyl]-3-(pyridin-2-yl)-4H-1,2,4-triazin-5-one derivatives were synthesized and tested for their in vitro antimycobacterial activity. Some compounds showed interesting activity against a strain of Mycobacterium tuberculosis.

Synthesis and antimycobacterial activity of some N1-[1-[3-aryl-1-(pyridin-2-, 3-, or 4-yl)-3-oxo]propyl]-2- pyridinecarboxamidrazones.

N1-[1-[3-aryl-1-(pyridin-2,3-, and 4-yl)-3-oxo[propyl]-2- pyridinecarboxamidrazone derivatives were synthesized and tested for their in vitro antimycobacterial activity. Some compounds showed interesting activity against a strain of Mycobacterium tuberculosis and a strain of Mycobacterium avium.

Synthesis and antimycobacterial activity of some indole derivatives of pyridine-2-carboxamidrazone and quinoline-2-carboxamidrazone.

A series of pyridine-2-carboxamidrazone and quinoline-2-carboxamidrazone derivatives containing the indole moiety was prepared. Some of the synthesized compounds showed an interesting in vitro antimycobacterial activity against a strain of Mycobacterium tuberculosis.

Synthesis and antimicrobial activity of some 2,5-disubstituted 1,3,4,-thiadiazole derivatives.

A series of 5-substituted 2-arylamino-1,3,4-thiadiazole derivatives was prepared. The antimicrobial activity of these compounds against some strains of bacteria and a strain of Candida albicans was determined, together with that of the corresponding thiosemicarbazone derivatives, which are intermediates in the synthetical procedure.

In-vitro antimycobacterial activity of new synthetic amidrazone derivatives.

After preliminary in vitro screening of 15 newly synthesized compounds belonging to the chemical class of N1-(aryliden)-4-pyridinecarboxyamidrazones against Mycobacterium tuberculosis reference strain H37 Rv, we determined the minimum inhibitory concentrations (MICs) of the six most promising chemicals against different species of Mycobacterium and different strains of M. tuberculosis. The agar dilution method was employed against M. gordonae, M. bovis, M. kansasi, M. avium, M. fortuitum and on eighteen different strains of M. tuberculosis, isolated from human bronchial aspirates. The results obtained confirmed that the newly synthesized chemicals possessed a very interesting antitubercular activity, their MICs ranging from 4 micrograms/ml to 16 micrograms/ml.

Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives.

A series of N1-aryliden-4-pyridinecarboxyamidrazone derivatives was prepared. Some of the synthesized compounds showed interesting in vitro antimycobacterial activity against some strains of Mycobacterium and clinical isolates of Mycobacterium tuberculosis.

Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives.

A series of N1-aryliden-2-pyridincarboxyamidrazone derivatives was prepared. Some of the synthesized compounds showed interesting in vitro antimycobacterial activity against some strains of Mycobacterium and clinical isolates of Mycobacterium tuberculosis.

Simultaneous determination of amiodarone and desethylamiodarone in human plasma by high performance liquid chromatography.

A rapid, sensitive and specific reversed phase HPLC method for the simultaneous assay of amiodarone and its major metabolite desethylamiodarone in human serum has been developed. This method is suitable for pharmacokinetic studies and for monitoring of the drug and metabolite concentrations in serum of patients on both short and long-term therapy with amiodarone.

Preliminary evaluation of in-vitro antimycobacterial properties of N1-(aryliden)-2-pyridinecarboxyamidrazones.

After preliminary in vitro screening of 17 newly synthesized compounds belonging to the chemical class of N1-(aryliden)-2-pyridinecarboxyamidrazones, active against Mycobacterium tuberculosis H37Rv, the minimum inhibitory concentrations (MICs) of the ten most promising agents against three clinical isolates were determined by agar dilution. Compounds 12 and 14 were the most active, each inhibiting strain H37Rv at concentrations of 8 microg/ml and having a MIC of 16 microg/ml against the human isolates. The results obtained in this preliminary study confirmed the interesting antitubercular properties of these newly synthesized compounds and allowed us to carry out our investigations over a large number of isolated clinical strains.

Synthesis and antifungal activity of some amidrazone derivatives.

The synthesis and in vitro antifungal activity of some pyridincarboxyamidrazone derivatives are described. 2-pyridincarboxyamidrazone derivative (IIa) in comparison with miconazole showed an interesting even if low antimycotic activity.

Synthesis and antihypertensive activity of some 1,3,4-thiadiazole derivatives.

A series of 2-arylamino-1,3,4-thiadiazole derivatives was synthesized with the aim to find new antihypertensive compounds. The antihypertensive activity of some of these compounds was examined intraperitoneally in conscious spontaneously hypertensive rats (SHR). The tested compounds showed activity, but none of these possessed a higher potency than the reference substance guanabenz.